Printer Friendly

COMPANY INFORMATION
Afexa Life Sciences Inc. 9604 20 Ave Edmonton, AB T6N 1G1 Tel: (780) 432-0022 Toll-free: (888) 280-0022 Fax: (780) 432-7772 Contact Name Jane H. Tulloch Industry Pharmaceuticals		Key Executives John D. Moffatt, CEO Allan Cleiren, CFO Develops and commercializes patented technology to identify, extract and biologically standardize natural products that provide verifiable and provable health benefits.
FP ADVISOR COVERAGE Afexa Life Sciences Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/FXA $0.75 $0.98 $0.31 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 83,635 75.00 $0.01 Sept. 30/09 82.93% -30.87% -22.19% $78,685
ANNUAL FINANCIALS Periods ended: 12m Sept. 30/09 12m Sept. 30/08 12m Sept. 30/07 $000s $000s $000s Operating revenue 47,592 49,389 42,035 Net income 1,301 4,592 (9,831) Total assets 37,887 41,850 41,308 $ $ $ Earnings per share* 0.01 0.04 (0.09) % % % Return on equity 5.87 24.96 (50.38)   * Common

COMPANY NEWS

Results for 'Afexa Life Sciences Inc.' from past 30 days: No hits. (Links are to articles.)